Inflammation controls B lymphopoiesis by regulating chemokine CXCL12 expression

被引:211
|
作者
Ueda, Y [1 ]
Yang, KY [1 ]
Foster, SJ [1 ]
Kondo, M [1 ]
Kelsoe, G [1 ]
机构
[1] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA
来源
JOURNAL OF EXPERIMENTAL MEDICINE | 2004年 / 199卷 / 01期
关键词
bone marrow; innate immunity; TNF alpha; hematopoiesis; neutrophilia;
D O I
10.1084/jem.20031104
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Inflammation removes developing and mature lymphocytes from the bone marrow (BM) and induces the appearance of developing B cells in the spleen. BM granulocyte numbers increase after lymphocyte reductions to support a reactive granulocytosis. Here, we demonstrate that inflammation, acting primarily through tumor necrosis factor alpha (TNFalpha), mobilizes BM lymphocytes. Mobilization reflects a reduced CXCL12 message and protein in BM and changes to the BM environment that prevents homing by cells from naive donors. The effects of TNFalpha are potentiated by interleukin 1beta (IL-1beta), which acts primarily to expand the BM granulocyte compartment. Our observations indicate that inflammation induces lymphocyte mobilization by suppressing CXCL12 retention signals in BM, which, in turn, increases the ability of IL-1beta to expand the BM granulocyte compartment. Consistent with this idea, lymphocyte mobilization and a modest expansion of BM granulocyte numbers follow injections of pertussis toxin. We propose that TNFalpha and IL-1beta transiently specialize the BM to support acute granulocytic responses and consequently promote extramedullary lymphopoiesis.
引用
收藏
页码:47 / 57
页数:11
相关论文
共 50 条
  • [21] Molecular characterization and expression analysis of chemokine (CXCL12) from Nile tilapia (Oreochromis niloticus)
    Gao, Along
    Yan, Fangfang
    Zhou, Enxu
    Wu, Liting
    Li, Lan
    Chen, Jianlin
    Lei, Yang
    Ye, Jianmin
    FISH & SHELLFISH IMMUNOLOGY, 2020, 104 : 314 - 323
  • [22] microRNA-23 inhibits inflammation to alleviate rheumatoid arthritis via regulating CXCL12
    Gao, Bo
    Sun, Guomin
    Wang, Yan
    Geng, Yaqin
    Zhou, Lei
    Chen, Xi
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2021, 21 (05)
  • [23] Changes in CXCL12/CXCR4-chemokine expression during onset of colorectal malignancies
    Frick, Vilma Oliveira
    Rubie, Claudia
    Ghadjar, Pirus
    Faust, Sabrina K.
    Wagner, Mathias
    Graeber, Stefan
    Schilling, Martin K.
    TUMOR BIOLOGY, 2011, 32 (01) : 189 - 196
  • [24] The chemokine CXCL12 regulates monocyte-macrophage differentiation and RUNX3 expression
    Sanchez-Martin, Lorena
    Estecha, Ana
    Samaniego, Rafael
    Sanchez-Ramon, Silvia
    Angel Vega, Miguel
    Sanchez-Mateos, Paloma
    BLOOD, 2011, 117 (01) : 88 - 97
  • [25] CXC chemokine ligand 12 (CXCL12) in atherosclerosis: An underlying therapeutic target
    Gao, Jia-Hui
    Yu, Xiao-Hua
    Tang, Chao-Ke
    CLINICA CHIMICA ACTA, 2019, 495 : 538 - 544
  • [26] MiR-135b Alleviates Airway Inflammation in Asthmatic Children and Experimental Mice with Asthma via Regulating CXCL12
    Liu, Ying
    Huo, Shi-Guang
    Xu, Ling
    Che, Yuan-Yuan
    Jiang, Shi-Yuan
    Zhu, Li
    Zhao, Min
    Teng, Yue-Chun
    IMMUNOLOGICAL INVESTIGATIONS, 2022, 51 (03) : 496 - 510
  • [27] The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer
    A Popple
    L G Durrant
    I Spendlove
    P Rolland
    I V Scott
    S Deen
    J M Ramage
    British Journal of Cancer, 2012, 106 : 1306 - 1313
  • [28] Role of the chemokine CXCL12 in the estrogen response of breast cancer cells
    Hawsawi, Nahed M.
    CANCER RESEARCH, 2011, 71
  • [29] Polymorphism and circulating levels of the chemokine CXCL12 in colorectal cancer patients
    Dimberg, Jan
    Hugander, Anders
    Lofgren, Sture
    Wagsater, Dick
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2007, 19 (01) : 11 - 15
  • [30] The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer
    Popple, A.
    Durrant, L. G.
    Spendlove, I.
    Rolland, P.
    Scott, I. V.
    Deen, S.
    Ramage, J. M.
    BRITISH JOURNAL OF CANCER, 2012, 106 (07) : 1306 - 1313